FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361288586> ?p ?o ?g. }

• W4361288586 endingPage "89" @default.
• W4361288586 startingPage "78" @default.
• W4361288586 abstract "Purpose of the study . To evaluate the results of first‑line treatment in patients with metastatic castration‑resistant prostate cancer (mCRPC). Patients and methods . The evaluation of own clinical observations of 25 patients with mCRPC for the period from July 2014 to July 2021 by random sampling is given. Patients are divided into the ISUP group, the status of the initial treatment, and the type of previous treatment. Therapy was determined by the nature of progression. The following drugs were used as therapeutic agents: docetaxel, enzalutamide, abiraterone acetate + prednisolone, strontium (89 150 mBq). Results evaluation was carried out by RECIST 1.1. criteria. Statistical data processing was carried out using programs SPSS Statistica 2.0. Results . When assessing the tumor response to the therapy in 2 (8 %) patients, a complete therapeutic response was obtained, partial was registered in 4 (16 %) cases, stabilization in 9 (36 %), progression in 10 (40 %). The main response was stabilization and partial response, which was noted in 13 (52 %) patients. On 11 (44 %) patients with bone metastases as the cause of mCRPC, enzalutamide showed the best effect. Patients with lymph node metastases 3 (12 %) had a partial and complete response with a combined treatment regimen – lymphadenectomy + enzalutamide. In the group of patients n = 9 (36 %) – metastases to lymph nodes and bones, the best effect in the form of stabilization and partial response in enzalutamide. In 1 (4 %) patient with visceral progressing metastatic pleural lesion. Two patients had passed away by the end of the research. Conclusion . Enzalutamide and abiraterone showed the best responses in metastatic bone damage (as the cause of mCRPC). We observed more than 50 % of stabilizations during enzalutamide treatment. Combined treatment regimens should be used among patients with only metastatic lymph node lesion (oligo metastasis): this makes it possible to achieve a complete response and a greater number of stabilizations in some patients." @default.
• W4361288586 created "2023-03-31" @default.
• W4361288586 creator A5003912566 @default.
• W4361288586 creator A5062860873 @default.
• W4361288586 creator A5074619608 @default.
• W4361288586 creator A5091030233 @default.
• W4361288586 date "2023-03-26" @default.
• W4361288586 modified "2023-09-26" @default.
• W4361288586 title "Therapy results of patients with metastatic castration‑resistant prostate cancer. Regional experience" @default.
• W4361288586 cites W1904433804 @default.
• W4361288586 cites W2055346449 @default.
• W4361288586 cites W2077301757 @default.
• W4361288586 cites W2103090668 @default.
• W4361288586 cites W2112304044 @default.
• W4361288586 cites W2141569270 @default.
• W4361288586 cites W2144827656 @default.
• W4361288586 cites W2167749314 @default.
• W4361288586 cites W2184609419 @default.
• W4361288586 cites W2236020469 @default.
• W4361288586 cites W2239698670 @default.
• W4361288586 cites W2241285440 @default.
• W4361288586 cites W2755685704 @default.
• W4361288586 cites W2787804990 @default.
• W4361288586 cites W3126154428 @default.
• W4361288586 doi "https://doi.org/10.17709/2410-1893-2023-10-1-7" @default.
• W4361288586 hasPublicationYear "2023" @default.
• W4361288586 type Work @default.
• W4361288586 citedByCount "0" @default.
• W4361288586 crossrefType "journal-article" @default.
• W4361288586 hasAuthorship W4361288586A5003912566 @default.
• W4361288586 hasAuthorship W4361288586A5062860873 @default.
• W4361288586 hasAuthorship W4361288586A5074619608 @default.
• W4361288586 hasAuthorship W4361288586A5091030233 @default.
• W4361288586 hasBestOaLocation W43612885861 @default.
• W4361288586 hasConcept C121608353 @default.
• W4361288586 hasConcept C126322002 @default.
• W4361288586 hasConcept C126894567 @default.
• W4361288586 hasConcept C143998085 @default.
• W4361288586 hasConcept C2775832370 @default.
• W4361288586 hasConcept C2776551883 @default.
• W4361288586 hasConcept C2777899217 @default.
• W4361288586 hasConcept C2780192828 @default.
• W4361288586 hasConcept C2780849966 @default.
• W4361288586 hasConcept C2781190966 @default.
• W4361288586 hasConcept C2781413609 @default.
• W4361288586 hasConcept C61367390 @default.
• W4361288586 hasConcept C71924100 @default.
• W4361288586 hasConceptScore W4361288586C121608353 @default.
• W4361288586 hasConceptScore W4361288586C126322002 @default.
• W4361288586 hasConceptScore W4361288586C126894567 @default.
• W4361288586 hasConceptScore W4361288586C143998085 @default.
• W4361288586 hasConceptScore W4361288586C2775832370 @default.
• W4361288586 hasConceptScore W4361288586C2776551883 @default.
• W4361288586 hasConceptScore W4361288586C2777899217 @default.
• W4361288586 hasConceptScore W4361288586C2780192828 @default.
• W4361288586 hasConceptScore W4361288586C2780849966 @default.
• W4361288586 hasConceptScore W4361288586C2781190966 @default.
• W4361288586 hasConceptScore W4361288586C2781413609 @default.
• W4361288586 hasConceptScore W4361288586C61367390 @default.
• W4361288586 hasConceptScore W4361288586C71924100 @default.
• W4361288586 hasIssue "1" @default.
• W4361288586 hasLocation W43612885861 @default.
• W4361288586 hasOpenAccess W4361288586 @default.
• W4361288586 hasPrimaryLocation W43612885861 @default.
• W4361288586 hasRelatedWork W122177069 @default.
• W4361288586 hasRelatedWork W2135620818 @default.
• W4361288586 hasRelatedWork W2464380321 @default.
• W4361288586 hasRelatedWork W2568045406 @default.
• W4361288586 hasRelatedWork W2590124563 @default.
• W4361288586 hasRelatedWork W2770702948 @default.
• W4361288586 hasRelatedWork W2982156914 @default.
• W4361288586 hasRelatedWork W3135865861 @default.
• W4361288586 hasRelatedWork W3181573761 @default.
• W4361288586 hasRelatedWork W4229076799 @default.
• W4361288586 hasVolume "10" @default.
• W4361288586 isParatext "false" @default.
• W4361288586 isRetracted "false" @default.
• W4361288586 workType "article" @default.